Cartesian Therapeutics Inc. Free Cash Flow Generation Index

Latest as of September 2024: 0.55x

Cartesian Therapeutics Inc. free cash flow generation index. Cartesian Therapeutics Inc. (RNAC) has a Free Cash Flow Generation Index of 0.55x as of September 2024. Free cash flow of $7.49 Million represents 1% of operating cash flow ($13.69 Million).

FCF Generation Index

0.55x
Free Cash Flow / Operating CF

Free Cash Flow

$7.49 Million
USD

Operating Cash Flow

$13.69 Million
USD

Capital Expenditures

$6.20 Million
USD

Free Cash Flow Generation Index of Cartesian Therapeutics Inc. (2020–2020)

Free cash flow generation index of Cartesian Therapeutics Inc. from 2020 to 2020. Historical FCF Generation Index trend for Cartesian Therapeutics Inc. across 1 annual periods. See Cartesian Therapeutics Inc. financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Cartesian Therapeutics Inc. Free Cash Flow Generation Index by Year (2020–2020)

Cartesian Therapeutics Inc. free cash flow generation index by year from 2020 to 2020. Year-by-year Free Cash Flow Generation Index for Cartesian Therapeutics Inc.. For the full cash flow conversion analysis, see RNAC cash flow metrics.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2020 0.98x $34.07 Million $34.88 Million $815.00K —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).